Visit Us at Booth 19

IMMUNO-ONCOLOGY 360°

February 27 – 29, 2024 | New York, NY

Discover the latest innovations in cancer research with us at the 10th Annual Immuno-Oncology 360° (IO360°) Conference! We are thrilled to showcase our enhanced Oncology CRO services at the upcoming meeting in Brooklyn, New York, taking place from February 27-29th. Visit us at Booth 19 and discover how our diverse capabilities can support both your current and future research endeavors. Your innovation is our priority!

Click here to schedule a meeting or stop by Booth 19 and speak with Srujana Cherukuri, Ph.D. or Yongping Chen, M.D., Ph.D., about how Noble Life Sciences can advance your preclinical research.

We hope to see you in New York!

Learn More About Noble’s CRO Services:

Mouse models

  • Syngeneic Tumor Models
  • Orthotopic, Metastasis/Disseminated Xenograft Models
  • Humanized Mouse Models
  • Patient-derived Xenograft Models (PDX)
  • Cell Line-derived Xenograft Models (CDX)

Imaging

  • IVIS Optical Live Animal Imaging
  • Fluoroscopy Imaging System
  • Radiology
  • Ultrasound

In Vitro Assays

  • Expansion and Activation of CAR-T Cells (Proliferation, Activation, Cytolytic Activity & Cytokine Production of CAR-T Cells)
  • Flexibility to Build Out T-cell Production Capabilities
  • Flow Cytometry-Based Assays to Support Immuno-oncology Drug Development
  • Cytotoxicity and Immunotoxicity Assays
  • PK/PD and Efficacy Studies
  • Flow and PCR-based Biodistribution Assays
  • Cellular Activation and Stimulation Assays
  • Human Whole Blood Stimulation Assays

Meet the Noble Attendees

See Us at Booth 19

Srujana Cherukuri, Ph.D.

Chief Executive Officer

Yongping Chen, M.D., Ph.D.

Senior Study Director

Noble Life Sciences, is a global preclinical CRO dedicated to innovation and scientific discovery. Our team of dedicated scientists is committed to advancing new cancer immunotherapies, vaccines, and T-cell therapies. With expertise in developing targeted therapies, we aim to enhance patient outcomes.

IO360˚ offers unparalleled business development and networking opportunities, and we welcome one-on-one meetings to connect with fellow industry professionals.

Visit Us at Booth 19

IMMUNO-ONCOLOGY 360°

February 27 – 29, 2024 | New York Marriott At The Brooklyn Bridge | New York, NY